Huifang Wang

机构：National Medical Products Administration

发表论文 17 篇 · 总被引 91 次 · h-index 7

代表论文

• Reprogramming tumor microenvironment with precise photothermal therapy by calreticulin nanobody-engineered probiotics (2024 · Biomaterials · 被引 21)
• Off-the-shelf CAR-NK cells targeting immunogenic cell death marker ERp57 execute robust antitumor activity and have a synergistic effect with ICD inducer oxaliplatin (2024 · Journal for ImmunoTherapy of Cancer · 被引 14)
• CDH17-targeting CAR-NK cells synergize with CD47 blockade for potent suppression of gastrointestinal cancers (2025 · Acta Pharmaceutica Sinica B · 被引 11)
• Identification and Characterization of CD133pos Subpopulation Cells From a Human Laryngeal Cancer Cell Line (2016 · Medical Science Monitor · 被引 11)
• Inhibitory Effects of Plumbagin on Retinal Pigment Epithelial Cell Epithelial-Mesenchymal Transition In Vitro and In Vivo (2018 · Medical Science Monitor · 被引 10)
• Coinhibition of activated p38 MAPKα and mTORC1 potentiates stemness maintenance of HSCs from SR1-expanded human cord blood CD34+ cells via inhibition of senescence (2020 · Stem Cells Translational Medicine · 被引 9)